Fludarabine/full dose i.v. busulfan conditioning regimen in allogeneic PBSC transplantation for high risk patients

被引:0
|
作者
Chunduri, S. [1 ]
Dobogai, L. C. [1 ]
Peace, D. [1 ]
Saunthararajah, Y. [1 ]
Quigley, J. [1 ]
Chen, Y. -H. [1 ]
Boccuni, P. [1 ]
Hoffman, R. [1 ]
Mahmud, N. [1 ]
Beri, R. [1 ]
Hurter, E. [1 ]
Rondelli, D. [1 ]
机构
[1] Univ Illinois, Hematol Oncol Sect, Chicago, IL USA
关键词
D O I
10.1016/j.bbmt.2006.12.235
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
230
引用
收藏
页码:84 / 84
页数:1
相关论文
共 50 条
  • [21] Allogeneic stem cell transplantation (BMT) for AML and MDS following i.v. busulfan and cyclophosphamide (i.v. BuCy)
    BS Andersson
    J Gajewski
    M Donato
    S Giralt
    V Gian
    J Wingard
    S Tarantolo
    H Fernandez
    WW Hu
    K Blume
    A Kashyap
    SJ Forman
    RE Champlin
    Bone Marrow Transplantation, 2000, 25 : S35 - S38
  • [22] Allogeneic stem cell transplantation (BMT) for AML and MDS following i.v. busulfan and cyclophosphamide (i.v. BuCy)
    Andersson, BS
    Gajewski, J
    Donato, M
    Giralt, S
    Gian, V
    Wingard, J
    Tarantolo, S
    Fernandez, H
    Hu, WW
    Blume, K
    Kashyap, A
    Forman, SJ
    Champlin, RE
    BONE MARROW TRANSPLANTATION, 2000, 25 (Suppl 2) : S35 - S38
  • [23] HIGH-DOSE BUSULFAN AND MELPHALAN AS CONDITIONING REGIMEN PRIOR TO TRANSPLANTATION
    MARIT, G
    CONY, P
    DAVID, B
    BROUSTET, A
    REIFFERS, J
    BONE MARROW TRANSPLANTATION, 1988, 3 : 78 - 78
  • [24] Fludarabine and busulfan (FluBuP regimen) as myeloablative conditioning regimen for allogeneic PBSCT in 71 leukemic patients (A unicenteric study).
    Iravani, M
    Tavakoli, M
    Shamshiri, AR
    Evazi, MR
    Mousavi, A
    Bahar, B
    Ghavamzadeh, A
    BLOOD, 2004, 104 (11) : 373B - 373B
  • [25] Comparable kinetics of myeloablation between fludarabine/full-dose busulfan and fludarabine/melphalan conditioning regimens in allogeneic peripheral blood stem cell transplantation
    S Chunduri
    L C Dobogai
    D Peace
    Y Saunthararajah
    H Y Chen
    N Mahmud
    J Quigley
    R Hoffman
    E Jessop
    R Beri
    D Rondelli
    Bone Marrow Transplantation, 2006, 38 : 477 - 482
  • [26] Comparable kinetics of myeloablation between fludarabine/full-dose busulfan and fludarabine/melphalan conditioning regimens in allogeneic peripheral blood stem cell transplantation
    Chunduri, S.
    Dobogai, L. C.
    Peace, D.
    Saunthararajah, Y.
    Chen, H. Y.
    Mahmud, N.
    Quigley, J.
    Hoffman, R.
    Jessop, E.
    Beri, R.
    Rondelli, D.
    BONE MARROW TRANSPLANTATION, 2006, 38 (07) : 477 - 482
  • [27] Fludarabine and busulfan as a reduced-toxicity myeloablative conditioning regimen in allogeneic hematopoietic stem cell transplantation for acute leukemia patients
    Dai, Zhiming
    Liu, Jie
    Zhang, Wang-Gang
    Cao, Xingmei
    Zhang, Yang
    Dai, Zhijun
    MOLECULAR AND CLINICAL ONCOLOGY, 2016, 4 (04) : 667 - 671
  • [28] New myeloablative conditioning regimen with fludarabine and busulfan for allogeneic stem cell transplantation: comparison with BuCy2
    Sohn, S. K.
    Chae, Y. S.
    Kim, J. G.
    Cho, Y. Y.
    Moon, J. H.
    Shin, H. J.
    Chung, J. S.
    Cho, G. J.
    Yang, D. H.
    Lee, J. J.
    Kim, Y. K.
    Kim, H. J.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S203 - S204
  • [29] New myeloablative conditioning regimen with fludarabine and busulfan for allogeneic stem cell transplantation: comparison with BuCy2
    Chae, Y. S.
    Sohn, S. K.
    Kim, J. G.
    Cho, Y. Y.
    Moon, J. H.
    Shin, H. J.
    Chung, J. S.
    Cho, G. J.
    Yang, D. H.
    Lee, J-J
    Kim, Y-K
    Kim, H-J
    BONE MARROW TRANSPLANTATION, 2007, 40 (06) : 541 - 547
  • [30] New myeloablative conditioning regimen with fludarabine and busulfan for allogeneic stem cell transplantation: comparison with BuCy2
    Y S Chae
    S K Sohn
    J G Kim
    Y Y Cho
    J H Moon
    H J Shin
    J S Chung
    G J Cho
    D H Yang
    J-J Lee
    Y-K Kim
    H-J Kim
    Bone Marrow Transplantation, 2007, 40 : 541 - 547